Correlation Between Bavarian Nordic and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Bavarian Nordic and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bavarian Nordic and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bavarian Nordic AS and Vaxcyte, you can compare the effects of market volatilities on Bavarian Nordic and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bavarian Nordic with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bavarian Nordic and Vaxcyte.
Diversification Opportunities for Bavarian Nordic and Vaxcyte
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Bavarian and Vaxcyte is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Bavarian Nordic AS and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Bavarian Nordic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bavarian Nordic AS are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Bavarian Nordic i.e., Bavarian Nordic and Vaxcyte go up and down completely randomly.
Pair Corralation between Bavarian Nordic and Vaxcyte
Assuming the 90 days horizon Bavarian Nordic AS is expected to generate 1.27 times more return on investment than Vaxcyte. However, Bavarian Nordic is 1.27 times more volatile than Vaxcyte. It trades about -0.01 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.18 per unit of risk. If you would invest 953.00 in Bavarian Nordic AS on October 7, 2024 and sell it today you would lose (38.00) from holding Bavarian Nordic AS or give up 3.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Bavarian Nordic AS vs. Vaxcyte
Performance |
Timeline |
Bavarian Nordic AS |
Vaxcyte |
Bavarian Nordic and Vaxcyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bavarian Nordic and Vaxcyte
The main advantage of trading using opposite Bavarian Nordic and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bavarian Nordic position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.Bavarian Nordic vs. Mineralys Therapeutics, Common | Bavarian Nordic vs. Anebulo Pharmaceuticals | Bavarian Nordic vs. Bioatla | Bavarian Nordic vs. Bicycle Therapeutics |
Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |